Amrutanjan Health Care Limited has informed the Exchange that Board of Directors at its meeting held on May 08, 2026, recommended Final Dividend of Rs. 2.90 per equity share.
AMRUTANJAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts more than Nifty Microcap 250 and 0.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Amrutanjan Health Care Limited reported strong FY2025-26 results with revenue from operations growing 11.2% to Rs 50,255.27 lakhs from Rs 45,181.63 lakhs in FY2024-25. Profit after tax increased 13.9% to Rs 5,791.78 lakhs from Rs 5,083.47 lakhs. Basic and diluted EPS rose to Rs 20.03 from Rs 17.58. The Board recommended a Final Dividend of Rs 2.90 per equity share (face value Rs 1) for FY2025-26, subject to shareholder approval at AGM. The company also appointed Mr. Ramaswami Krishnan as Additional Non-Executive Independent Director and re-appointed Mr. Muralidharan Swayambunathan for another 5-year term. Additionally, the Board approved rolling out the revised ESOP Phase 2 scheme. The statutory auditors issued an unmodified opinion on the financial results.
The 14% growth in PAT and improved EPS indicate healthy operational performance. The dividend of Rs 2.90 per share offers a reasonable return to shareholders. The appointments strengthen board governance. Overall, these results should be viewed positively by investors given the consistent growth trajectory and clean audit opinion.